HLA-C and cancer: The activation of T γδ lymphocytes in MLN is interesting since the characteristics of these cells make them potential agents for cancer immunotherapy: cellular tropism, antitumor activity independent of neoantigen loading, and conventional presentation of MHC-dependent antigens, in addition to presenting a combination of typical functions of T cells and natural killer cells [41].